English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

1. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990;142:940–53. 2. Lloveras J, Peterson PK, Simmons R, Najerian S. Mycobacterial infections in renal transplant recipients. Arch Intern Med 1982;142:888–92. 3. Novick RJ, Moreno-Cabral CE, Stinson EB, et al. The nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant 1990;9:357–63. 4. Tuder RM, Renya GS, Bensch K. Mycobacterial coronary arteritis in a heart transplant recipient. Hum Pathol 1986;17:1072–4. 5. LeMense GP, Van Bakel AB, Crumbley J, Judson MA. Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipient. Chest 1994;106:1918–20. 6. Tebas P, Sultan F, Wallace J, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995;20: 443–4. 7. Zappe CH, Barlow D, Zappe H, Bolton IJ, Roditi D, Steyn LM. 16S rRNA sequence analysis of an isolate of Mycobacterium haemophilum from a heart transplant patient. J Med Microbiol 1995;43:189–91. 8. Cooper DKC, Lanza RP, Oliver S, et al. Infectious complications after heart transplantation. Thorax 1983;38:822–8. 9. Lederman C, Spitz JL, Scully B, Schulman LL, et al. Mycobacterium haemophilum cellulitis in a heart transplant recipient. J Am Acad Dermatol 1994;30:804–6. 10. Wallace RJ, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482–6. 11. Patel R, Roberts GD, Keating MR, Paya C. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994;19:263–73. 12. Plemmons RM, Mc Allister CK, Garcés MC, Ward RL. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. Clin Infect Dis 1997;24:995–7. 13. Kochar S, Indudhara R, Nagi B, Yadav RVS, Mehta SK. Colonic tuberculosis due to atypical mycobacteria in a renal transplant recipient. Am J Gastroenterol 1988;83:1435–6. 14. Muller-Hermelink HK, Kaiserling E, Sonntag HG. Modulation of epithelioid cell granuloma formation to a pathogenic mycobacteria by cyclosporin A. Pathol Res Pract 1982;175:80–5.

Native Valve Endocarditis Due to Mycobacterium fortuitum biovar fortuitum: Case Report and Review